Clarity Pharmaceuticals Ltd (CU6) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

AU Stock MarketDetailed Quotes

CU6 Clarity Pharmaceuticals Ltd

Watchlist

3.330
+0.030+0.91%

20min DelayTrading Feb 17 11:22 AET

1.07BMarket Cap-21.48P/E (Static)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Clarity Pharmaceuticals Combines Antibody With Proprietary Technology For Breast Cancer Therapy, Shares Fall 6%
MT NewswiresFeb 10 19:49 ET
Clarity Pharmaceuticals (ASX:CU6) Is In A Strong Position To Grow Its Business
Yahoo FinanceJan 30 16:25 ET
Guess Which ASX 200 Biotech Stock Is Jumping 15% on Big US FDA News
The Motley FoolJan 23 18:58 ET
Clarity Pharmaceuticals Announces ASX Quotation of New Securities
TipRanksJan 21 23:57 ET
Clarity Pharmaceuticals Issues New Shares Without Disclosure
TipRanksJan 21 23:57 ET
Here Are the Top 10 ASX 200 Shares Today
The Motley FoolJan 7 01:03 ET

Comments

Moomoo News AU

Dec 18, 2024 00:31

Columns AU Evening Wrap | ASX 200 down slightly, Omni Bridgeway soars 50%

Top gainers: $Megaport Ltd (MP1.AU)$, $Cettire Ltd (CTT.AU)$ and $Growthpoint Properties Australia (GOZ.AU)$
Top losers: $Zimplats Holdings Ltd (ZIM.AU)$, $Coronado Global Resources Inc (CRN.AU)$ and $Insignia Financial Ltd (IFL.AU)$
$S&P/ASX 200 (.XJO.AU)$ closed down 0.06%, or 4.6 points, at 8309.40 points, reversing early gains. This was due to a more risk-averse investor approach ahead of the US Federal Reserve's interest rate decisio...

Can the Santa Claus rally happen after the Fed's hawkish cut?

Sanjeev Kaushik

Jul 17, 2024 01:02

General Recommendation: Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd (ASX: CU6)
Target: 7.04
Stop Loss: 4.3
Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.
Note: The closing must be tracked on weekly basis i.e you should exit the ...

Trending Stocks

Symbol Div YieldTTM Dividend TTM

Unlock the Full List